Senior Appointment to Drive Strategic Development 

CRO provider Envigo has appointed Lynn Lewis as Senior Vice President, Global Sales. She brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals and leadership roles within sales and operations in the contract research organisation (CRO) industry. “Given the dynamic growth in the CRO industry, there is an increasing opportunity to further engage our existing customers, as well as attract emerging life sciences companies to Envigo’s extensive non-clinical service offerings and research products. We are thrilled that Lynn Lewis has joined our team to drive this important effort,” said Dr. Adrian Hardy, President and Chief Executive Officer. “Lynn’s broad experience leading billion dollar, successful global sales organisations serving the biopharmaceutical industry will be an invaluable asset to our commercial team.”

Prior to joining Envigo, Lynn was most recently Group Vice President of Business Development, Clinical Development and Commercialisation Services for Covance, where she also led the global sales organisations for the company’s nonclinical and central laboratory businesses. She also served as the General Manager of Covance’s drug discovery and development campus in Greenfield, Indiana. Before joining Covance, Lynn worked for Eli Lilly and Company leading cross functional development teams to bring new medicines to market. She holds a Master of Business Administration from University of North Carolina at Chapel Hill and a Bachelor of Science degree in Biology from Bucknell University.